Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
Herrero
J I
JI
Liver Unit, Clínica Universitaria de Navarra, Pamplona, Spain.
Quiroga
J
J
Sangro
B
B
Sola
I
I
Riezu-Boj
J I
JI
Pardo
F
F
Prieto
J
J
D000208:Acute Disease; D001663:Bilirubin / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000821:virology; D016031:Liver Transplantation; D011183:Postoperative Complications / Q000188:drug therapy*; D012008:Recurrence; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000637:Transaminases / Q000097:blood
D004279:DNA, Viral; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000637:Transaminases; D001663:Bilirubin